related announcements
Finance
-
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
-
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
-
Results from a Phase 1 First in human Study of Pemivibart: an[...]
Company News
Credit Suisse Asset Management Income Fund Inc.
08/14/2012 | Press release | Archived content
August 14, 2012: CIK Second Quarter Earnings Release
Sharing and Personal Tools
Please select the service you want to use:
Smartlinks | Credit Suisse Asset Management Income Fund Inc. | Credit Suisse Asset Management LLC | Finance | Security Markets | Security Markets | Company News | Corporate Debt | Financial Services | Investment Services | Closed-End Funds | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact